Qube Research & Technologies (QRT)’s bluebird bio BLUE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-56,229	Closed	-$1.55M	–	4474
2023 Q4	$1.55M	Buy	+56,229	New	+$3.43M	﹤0.01%	1669
2023 Q2	–	Sell	-36,616	Closed	-$2.33M	–	2417
2023 Q1	$2.33M	Buy	36,616 +9,177	+33%	+$1.05M	0.01%	940
2022 Q4	$3.8M	Buy	+27,439	New	+$3.87M	0.02%	732
2022 Q3	–	Sell	-20,266	Closed	-$1.68M	–	2526
2022 Q2	$1.68M	Buy	20,266 +13,751	+211%	+$1.07M	0.01%	885
2022 Q1	$632K	Buy	+6,515	New	+$860K	0.01%	1412
2021 Q1	–	Sell	-5,208	Closed	-$2.92M	–	1924
2020 Q4	$2.92M	Buy	5,208 +3,629	+230%	+$2.3M	0.04%	472
2020 Q3	$1.1M	Buy	1,579 +42	+3%	+$32.8K	0.02%	781
2020 Q2	$1.22M	Buy	1,537 +63	+4%	+$47.5K	0.02%	801
2020 Q1	$878K	Buy	1,474 +1,291	+705%	+$1.26M	0.04%	424
2019 Q4	$208K	Buy	+183	New	+$199K	0.01%	1374

Other funds holding BLUE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BLUE Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 56,229 shares — an estimated $1.55M sold.

Qube Research & Technologies (QRT) first reported a position in BLUE in Q4 2019 and held it in 10 quarters. The position peaked at $3.8M in Q4 2022. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

Qube Research & Technologies (QRT) reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 56,229 bluebird bio shares in Q1 2024, an estimated $1.55M.
Qube Research & Technologies (QRT) first reported a position in bluebird bio in Q4 2019 and held it in 10 quarters.
Qube Research & Technologies (QRT)'s bluebird bio position peaked at $3.8M in Q4 2022.
158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.